A detailed history of Bayesian Capital Management, LP transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Bayesian Capital Management, LP holds 8,800 shares of DGX stock, worth $1.21 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
8,800
Holding current value
$1.21 Million
% of portfolio
0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$125.91 - $144.34 $1.11 Million - $1.27 Million
8,800 New
8,800 $1.2 Million
Q4 2022

Feb 14, 2023

BUY
$123.31 - $157.26 $636,649 - $811,933
5,163 Added 211.86%
7,600 $1.19 Million
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $52,848 - $61,237
-434 Reduced 15.12%
2,437 $299,000
Q2 2022

Aug 15, 2022

BUY
$127.07 - $145.39 $364,817 - $417,414
2,871 New
2,871 $382,000
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $224,576 - $276,816
-1,600 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $212,719 - $252,800
1,600 New
1,600 $232,000
Q4 2020

Feb 12, 2021

SELL
$112.7 - $128.05 $1.52 Million - $1.72 Million
-13,463 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$107.05 - $130.01 $1.09 Million - $1.32 Million
10,163 Added 307.97%
13,463 $1.54 Million
Q2 2020

Aug 14, 2020

BUY
$73.34 - $122.61 $242,022 - $404,613
3,300 New
3,300 $376,000
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $668,746 - $1.03 Million
-8,900 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$100.29 - $107.99 $220,638 - $237,578
2,200 Added 32.84%
8,900 $950,000
Q3 2019

Nov 13, 2019

BUY
$97.85 - $107.42 $655,595 - $719,714
6,700 New
6,700 $717,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.